PRE-TRANSPLANT CHEMOTHERAPY DOES NOT AFFECT POST TRANSPLANT OUTCOME IN PATIENTS UNDERGOING OHT FOR AL CARDIOMYOPATHY

N Sarswat,Emily Niehaus,Sara Tabtabai,J R Stone,Lauren Gilstrap,Matthew Maurer,R Witteles,J D Estep,D A Baran,M J Zucker,David C Seldin,Marc J Semigran

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2014）

引用 0|浏览13

暂无评分

摘要

Light-chain (AL) cardiac amyloidosis can be treated with cardiac transplantation (HT) followed by high dose melphalan chemotherapy and autologous stem cell transplant. We hypothesized that chemotherapy (CTX) prior to HT targeting clonal plasma cell light chain production may lead to improved

查看译文

关键词

Cardiac Amyloidosis,Light Chain Amyloidosis,Treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要